ClinConnect ClinConnect Logo
Search / Trial NCT03786185

Neuroplasticity of Multisensory Cortical Areas Induced by Musical Training: a Translational Approach (MusicPlast)

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Dec 21, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Neuroplasticity Computerized Training Music Reading Multisensory Training

ClinConnect Summary

The MusicPlast trial is studying how musical training can help improve brain functions related to hearing, seeing, and understanding for people with dyslexia and age-related cognitive issues. By using a special computer program that provides multisensory training—meaning it involves multiple senses like sound and sight—the researchers aim to see if this training can change the way the brain works and helps participants learn better. The ultimate goal is to understand how these brain changes happen and to create effective training programs for those who need it most.

To participate, candidates should be either adolescents aged 13-18 with diagnosed dyslexia or healthy controls in the same age range, as well as young adults aged 18-35 or seniors aged 65-100 who are cognitively healthy. All participants should have normal hearing and vision. Throughout the study, participants will engage in the training and have their brain activity measured through various tests before and after the training to see how it affects their brain function. This research is being conducted at the Aristotle University of Thessaloniki, where experts in music and neuroscience are working together to bring valuable insights into how music can benefit cognitive health.

Gender

ALL

Eligibility criteria

  • Group of Adolescent dyslectics
  • Inclusion Criteria:
  • 13 - 18 years of age
  • normal or corrected-to-normal hearing and vision
  • Diagnosed dyslexia
  • Exclusion Criteria:
  • any other than dyslexia, diagnosed neurological, mental, developmental or psychiatric disorder
  • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
  • (iii) unstable medication within the last 3 months,
  • (iv) severe physical disorder, and
  • (v) concurrent participation in another relevant study.
  • Group of Adolescent controls
  • Inclusion Criteria:
  • 13 - 18 years of age
  • normal or corrected-to-normal hearing and vision
  • Exclusion Criteria:
  • (I) any diagnosed neurological, mental, developmental or psychiatric disorder
  • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
  • (iii) unstable medication within the last 3 months,
  • (iv) severe physical disorder, and
  • (v) concurrent participation in another relevant study.
  • Group of Young Adults
  • Inclusion Criteria:
  • 18 - 35 years of age
  • normal or corrected-to-normal hearing and vision
  • Exclusion Criteria:
  • (I) any diagnosed neurological, mental, developmental or psychiatric disorder
  • (ii) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
  • (iii) unstable medication within the last 3 months,
  • (iv) severe physical disorder, and
  • (v) concurrent participation in another relevant study.
  • Group of Seniors
  • Inclusion Criteria:
  • 65 - 100 years of age
  • normal or corrected-to-normal hearing and vision
  • normal score in a neuropsychological screening procedure which regards cognitive functionality
  • Exclusion Criteria:
  • (i) unrecovered neurological disorders (i.e., stroke, traumatic brain injury),
  • (ii) severe depression or psychological disorder,
  • (iii) unstable medication within the last 3 months,
  • (iv) severe physical disorder, and
  • (v) concurrent participation in another relevant study.

About Aristotle University Of Thessaloniki

Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.

Locations

Thessaloníki, , Greece

Patients applied

0 patients applied

Trial Officials

Evangelos Paraskevopoulos, PhD

Principal Investigator

Research Associate

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials